Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Trial ID or NCT#
Status
Purpose
This study is designed to establish the prevalence of anal squamous intraepithelial lesion (ASIL) in patients with inflammatory bowel disease (IBD) and healthy controls.
Official Title
Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Eligibility Criteria
- - All IBD patients followed in the IBD clinic and healthy controls who are greater than 18 years old
- - History of HPV vaccination - Pregnancy - Other immunosuppressed states (i.e. systemic lupus erythematosus, rheumatoid arthritis, cancer, Human Immunodeficiency Virus (HIV), transplant) - IBD patients who don't meet immunosuppression/non-immunosuppression criteria - Inability to obtain informed consent from patient - Previous diagnosis of ASIL or anal/rectal cancer
Contact us to find out if this trial is right for you.
Contact
Shamita Shah, MD
650-736-0431
View on ClinicalTrials.gov